What is Clora?
Founded in 2015, Clora operates as a sophisticated digital marketplace designed to connect life science companies with a curated network of on-demand experts. The platform addresses the inherent inefficiencies in traditional recruitment by utilizing intelligent matching algorithms that align specific project requirements with the precise skill sets of available professionals. This model is particularly advantageous for organizations navigating the complex regulatory and technical landscapes of the life sciences industry, where agility and specialized knowledge are paramount to operational success.
By facilitating a more fluid labor market, Clora enables companies to scale their research and development efforts without the overhead associated with traditional full-time hiring. The company's presence in the Boston innovation hub further cements its status as a key player in the digital health and biotech ecosystem, providing a scalable solution to the persistent challenge of sourcing niche talent in a rapidly evolving global market.
How much funding has Clora raised?
Clora has raised a total of $3.3M across 1 funding round:
Angel/Seed
$3.3M
Angel/Seed (2017): $3.3M with participation from Notation Capital, KohFounders, Social Capital, V1.vc, iSeed Ventures, Ludlow Ventures, and Spark Capital
Key Investors in Clora
Notation Capital
Notation Capital is a first-check venture fund based in Brooklyn, NY, focusing on very early-stage technical teams and providing essential capital to help startups scale.
Social Capital
Social Capital is an organization dedicated to solving the world's hardest problems by identifying critical challenges and assembling the necessary expertise and capital to execute effective solutions.
iSeed Ventures
iSeed Ventures is a San Francisco-based venture capital firm that invests in innovative companies across various sectors, particularly those leveraging AI technology to drive growth.
What's next for Clora?
With the infusion of this latest capital, Clora is well-positioned to accelerate its product development and expand its footprint within the enterprise-level life science market. The strategic focus will likely center on enhancing the platform's matching capabilities and deepening its integration with existing enterprise resource planning systems. As the demand for flexible labor models continues to rise, Clora's ability to maintain a high-quality talent pool will be the primary driver of its long-term valuation and market dominance.
Future growth initiatives are expected to prioritize the scaling of operations to support larger, multi-national clinical trials and research initiatives. By maintaining its commitment to high-touch, expert-led recruitment, Clora is poised to redefine the standard for professional staffing in the life sciences, potentially setting the stage for further institutional investment or strategic partnerships as it matures into a cornerstone of the industry's human capital infrastructure.
